ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

Provided By PR Newswire

Last update: Jul 17, 2023

RANCHO CORDOVA, Calif., July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the appointments of Biao Xi, Ph.D. and James Xu, Esq., DBA, PsyD., J.D., CPA to its Board, effective July 17, 2023. Both are independent directors. The appointments expand ThermoGenesis' Board to seven members.